Stereotaxis STXS
NYSE STXS
$1.42 -0.02 (-1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stereotaxis (STXS) Non-Current Deffered Revenue (2010 - 2026)

Stereotaxis (STXS) posted quarterly Non-Current Deffered Revenue of $523000.0 for Q1 2026, down 69.2% year-over-year from $1.7 million in Q1 2025, and down 5.77% quarter-over-quarter from $555000.0 in Q4 2025.

Stereotaxis (STXS) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Non-Current Deffered Revenue for 17 consecutive years, with $523000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue fell 69.2% year-over-year to $523000.0; the TTM figure through Mar 2026 stood at $523000.0 (down 69.2% YoY), while the FY2025 annual figure was $555000.0, down 73.11% from the prior year.
  • Non-Current Deffered Revenue declined to $523000.0 in Q1 2026 per STXS's latest filing, from $555000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $2.1 million in Q2 2024 and bottomed at $523000.0 in Q1 2026.
  • Historically, Non-Current Deffered Revenue has averaged $1.5 million across 5 years, with a median of $1.6 million in 2023.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue surged 56.29% — and 2025, when it tumbled 73.11%.
  • Stereotaxis' Non-Current Deffered Revenue stood at $1.7 million in 2022, then fell by 1.03% to $1.6 million in 2023, then rose by 26.08% to $2.1 million in 2024, then sank by 73.11% to $555000.0 in 2025, then fell by 5.77% to $523000.0 in 2026.
  • Business Quant data shows STXS's Non-Current Deffered Revenue at $523000.0 in Q1 2026, $555000.0 in Q4 2025, and $607000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 170.95 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 13.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 208.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Stereotaxis 141.91 Mn 127.29 Mn 3.79 Mn 523,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 523,000.00
Dec 31, 2025 555,000.00
Sep 30, 2025 607,000.00
Jun 30, 2025 1.06 Mn
Mar 31, 2025 1.70 Mn
Dec 31, 2024 2.06 Mn
Sep 30, 2024 2.10 Mn
Jun 30, 2024 2.12 Mn
Mar 31, 2024 1.58 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.98 Mn
Jun 30, 2023 1.64 Mn
Mar 31, 2023 1.71 Mn
Dec 31, 2022 1.65 Mn
Sep 30, 2022 1.42 Mn
Jun 30, 2022 1.63 Mn
Mar 31, 2022 2.08 Mn
Dec 31, 2021 2.24 Mn
Sep 30, 2021 1.79 Mn
Jun 30, 2021 1.65 Mn